Pharma Mar S.A. (PHM) — Cash Flow Reinvestment Rate

Latest as of December 2025: 1.74x

Pharma Mar S.A. (PHM) has a Cash Flow Reinvestment Rate of 1.74x as of December 2025, reinvesting €58.27 Million (capex €6.26 Million plus investments €-52.01 Million) from operating cash flow of €33.58 Million. Explore Pharma Mar S.A. capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.74x
(Capex + Investments) / Operating CF

Total Reinvested

€58.27 Million
Capex + Investments

Operating Cash Flow

€33.58 Million
EUR

Capital Expenditures

€6.26 Million
EUR

Pharma Mar S.A. Cash Flow Reinvestment Rate (2012–2025)

Historical reinvestment intensity for Pharma Mar S.A. across 9 annual periods. Also explore balance sheet size of Pharma Mar S.A. for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Pharma Mar S.A. (2012–2025)

Year-by-year capital reinvestment analysis for Pharma Mar S.A.. For live market cap and broader valuation context, see Pharma Mar S.A. market capitalisation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 1.24x €65.69 Million €53.13 Million €9.38 Million ▼ -55.0%
2024 2.74x €16.54 Million €6.03 Million €15.51 Million ▲ +433.1%
2022 0.51x €19.73 Million €38.32 Million €8.85 Million ▼ -61.2%
2021 1.33x €34.08 Million €25.68 Million €7.80 Million ▲ +211.1%
2020 0.43x €119.01 Million €278.94 Million €3.00 Million ▼ -83.2%
2015 2.55x €28.26 Million €11.10 Million €9.22 Million ▲ +144.8%
2014 1.04x €22.99 Million €22.11 Million €10.18 Million ▲ +421.6%
2013 0.20x €3.26 Million €16.34 Million €2.10 Million ▼ -37.9%
2012 0.32x €2.03 Million €6.32 Million €2.03 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow